Next‑generation genome sequencing of a matched normal‑tumor pair from a patient with intractable gestational choriocarcinoma: A case report

Albrecht C, Chamley L, Charnock-Jones DS, Collins S, Fujiwara H, Golos T, Grayo S, Hannan N, Harris L, Ichizuka K, et al: IFPA meeting 2018 workshop report II: Abnormally invasive placenta; inflammation and infection; preeclampsia; gestational trophoblastic disease and drug delivery. Placenta. 84:9–13. 2019.PubMed/NCBI View Article : Google Scholar

Yamamoto E, Niimi K, Fujikake K, Nishida T, Murata M, Mitsuma A, Ando Y and Kikkawa F: High-dose chemotherapy with autologous peripheral blood stem cell transplantation for choriocarcinoma: A case report and literature review. Mol Clin Oncol. 5:660–664. 2016.PubMed/NCBI View Article : Google Scholar

Powles T, Savage PM, Stebbing J, Short D, Young A, Bower M, Pappin C, Schmid P and Seckl MJ: A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia. Br J Cancer. 96:732–737. 2007.PubMed/NCBI View Article : Google Scholar

Sunami K, Ichikawa H, Kubo T, Kato M, Fujiwara Y, Shimomura A, Koyama T, Kakishima H, Kitami M, Matsushima H, et al: Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study. Cancer Sci. 110:1480–1490. 2019.PubMed/NCBI View Article : Google Scholar

Yamamoto E, Niimi K, Shinjo K, Yamamoto T, Fukunaga M and Kikkawa F: Identification of causative pregnancy of gestational trophoblastic neoplasia diagnosed during pregnancy by short tandem repeat analysis. Gynecol Oncol Case Rep. 9:3–6. 2014.PubMed/NCBI View Article : Google Scholar

Piamsomboon S, Kudelka AP, Termrungruanglert W, Van Besien K, Edwards CL, Lifshitz S, Schomer DF, Champlin R, Mante RP, Kavanagh JJ and Verschraegen CF: Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): First report and review of literature. Eur J Gynaecol Oncol. 18:453–456. 1997.PubMed/NCBI

van Besien K, Verschraegen C, Mehra R, Giralt S, Kudelka AP, Edwards CL, Piamsonboom S, Termrungruanglert W, Champlin R and Kavanagh JJ: Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue. Gynecol Oncol. 65:366–369. 1997.PubMed/NCBI View Article : Google Scholar

Zehir A, Benayed R, Shah RH, Syed A, Middha S, Kim HR, Srinivasan P, Gao J, Chakravarty D, Devlin SM, et al: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med. 23:703–713. 2017.PubMed/NCBI View Article : Google Scholar

Cotter JA, Szymanski L, Karimov C, Boghossian L, Margol A, Dhall G, Tamrazi B, Varaprasathan GI, Parham DM, Judkins AR and Biegel JA: Transmission of a TP53 germline mutation from unaffected male carrier associated with pediatric glioblastoma in his child and gestational choriocarcinoma in his female partner. Cold Spring Harb Mol Case Stud. 4(a002576)2018.PubMed/NCBI View Article : Google Scholar

Choi MC, Oh J and Lee C: Effective anti-programmed cell death 1 treatment for chemoresistant gestational trophoblastic neoplasia. Eur J Cancer. 121:94–97. 2019.PubMed/NCBI View Article : Google Scholar

Ghorani E, Kaur B, Fisher RA, Short D, Joneborg U, Carlson JW, Akarca A, Marafioti T, Quezada SA, Sarwar N and Seckl MJ: Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia. Lancet. 390:2343–2345. 2017.PubMed/NCBI View Article : Google Scholar